loader2
Partner With Us NRI

Bal Pharma Ltd share Price Today

Company details

105.45
110.00
63.35
118.35
6M Return 18.69%
1Y Return 18.75%
Mkt Cap.(Cr) 165.92
Volume 21,163
Div Yield 0.93%
OI
-
OI Chg %
-
Volume 21,163

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Bal Pharma Ltd Stocks COMPARISION

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 63.79 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 21,593.44 39,409.91
LAST 3M 57,905.00 19,139.45
LAST 6M 99,888.55 93,017.93
LAST 12M 166,353.23 137,771.51

Bal Pharma Ltd Information

Stock PE (TTM)
52.49
Promoter Holding
51.61%
Book Value
40.0965
ROCE
9.16%
ROE
4.28%
Description
  • Bal Pharma (BPL), a member of the Mcro Laboratories group, was incorporated as a private limited company in May `87. In Mar.`90, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations. BPL manufactures and markets pharmaceutical formulations -- paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxicam amoxycillin, etc. The company promotes its products through the common sales force of the group but proposes to induct its own soon. It came out with a public issue in Feb.`95 for manufacture of bulk drugs and expansion of pharmaceutical formulations. During 1997-98, the formalities of takeover of the unit from Lakme Limited have been completed and effective from 23rd July, 1997 the unit has become a division of Bal Pharma Limited. The company`s product range has been expanded with the introduction of AZIWIN, CAFIMOL & CORTIDERM. The company has added further product range Zanovid, Aziwin, Dry Syrup, Meloxi, Ocium - M, Progit - MPS in its ethical division during 1999-2000. As part of the expansion of the product range, the company has introduced Cardiac Specialities Products. To market these products, a new division named "SERVETUS" has started functioning during 2001. New products like Amiloride,Benzydamine and Ebastine were rolled into the market during 2002.

Registered Address

21 & 22 Bommasandra Indl Area, Hosur Road, Bangalore, Karnataka, 560092

Email : secretarial:balpharma.com/info:balpharma.com
Website : http://www.balpharma.com
Registrar

TSR Consultants P Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524824
NSE Code : BALPHARMA
Book Closure Date (Month) : Sep
BSE Group : B
ISIN : INE083D01012

FAQ’s on Bal Pharma Ltd Shares

You can buy Bal Pharma Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Bal Pharma Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Dec 08, 2023 02:14 PM the closing price of Bal Pharma Ltd was ₹ 105.75.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Dec 08, 2023 02:14 PM, the market cap of Bal Pharma Ltd stood at ₹ 165.92.

The latest PE ratio of Bal Pharma Ltd as of Dec 08, 2023 02:14 PM is 52.49

The latest PB ratio of Bal Pharma Ltd as of Dec 08, 2023 02:14 PM is 0.38

The 52-week high of Bal Pharma Ltd is ₹ 118.35 while the 52-week low is ₹ 63.35

Download Our App

market app
market app